Improving Documentation of Oral Chemotherapy at a Community Cancer Center

Enright, Katherine; MacMillan, Meghan; Lymburner, Patricia; Sodoski, Catherine; Gollee, Simerjit; Carvalho, Maritza; Dorn, Laurie Van; Fung, Ron; Almeida, Bernadette

doi:10.1200/jop.2014.003111

Cited by 7 publications

(10 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the journals, two had published seven (14.9%) articles in the Clin J Oncol Nurs [6][7]18,[27][28][34][35] (impact factor 0.881, Journal Citation Reports 2017-2018), six (12.8%) studies in the Oncol Nurs Forum 9,17,20,22,26,52 (impact factor 1.785, Journal Citation Reports 2017-2018), five (10.6%) in the J Oncol Pract 4,17,38,40,45 (impact factor 2.509, Journal Citation Reports 2017-2018) and in the Eur J Oncol Nurs 23,44,46,48,51 (impact factor 1.812, Journal Citation Reports 2017-2018), three (6.4%) publications in the J Pediatr Oncol Nurs 5,30,32 (impact factor 1.294, Journal Citation Reports 2017-2018), two (4.3%) in the Qual Saf Health Care 25,29 (according to the latest data, not indexed in the Journal Citation Reports). The other studies were published in different health journals.…”

Section: /18mentioning

confidence: 99%

“…In the standards and specific recommendations for the safe administration of oral anticancer drugs, the following were highlighted: prescriptions for oral chemotherapy (health sectors or other institution as residence) should include the patient's name, have a second individual identifier; full generic name of the drug; date of request, dose of drug with calculation methodology; administration schedule, administration mode, special instructions (if applicable); amount of drug to be dispensed and duration of therapy (number of cycles); monitoring of oral CTXs with periodic home visits; creation and implementation of institutional protocols (evidence-based care); advise on proper disposal if necessary. 4,9,14,16,23,31,35,[38][39]43 It is noteworthy that labels for medications dispensed from the health care environment to be taken at home include the following: patient's name; patient's second identifier; date of preparation and due date; full generic drug name, dose and dosage; amount dispensed into each vial; administration 11/18 schedule; administration instructions related to the ingestion of food and/or other medicines; warning or precautionary statement for storage and handling; warning label attached to the product (hazardous drug); storage conditions; name and number of the class council of the prescribing and responsible pharmacist. 4,16,38…”

Section: Good Practices For Patient Safety Using Oral Antineoplastic mentioning

confidence: 99%

“…4,9,14,16,23,31,35,[38][39]43 It is noteworthy that labels for medications dispensed from the health care environment to be taken at home include the following: patient's name; patient's second identifier; date of preparation and due date; full generic drug name, dose and dosage; amount dispensed into each vial; administration 11/18 schedule; administration instructions related to the ingestion of food and/or other medicines; warning or precautionary statement for storage and handling; warning label attached to the product (hazardous drug); storage conditions; name and number of the class council of the prescribing and responsible pharmacist. 4,16,38…”

Section: Good Practices For Patient Safety Using Oral Antineoplastic mentioning

confidence: 99%

“…However, over the past 15 years, the number of oral antineoplastic drugs and their use has increased significantly and is expected to continue. 14,[38][39] Due to the increasing use of oral chemotherapy, unique challenges associated with its use have emerged, especially regarding the prescription, dispensation, reimbursement, adherence, and education of the patient and family, with clear guidance on what is considered safe delivery of CTX. 9,35,43 In response to this need, CTX administration safety standards since 2016 have included specific oral CTX standards as well as the addition of specific oral cancer agent issues such as the need to monitor adherence.…”

Section: /18mentioning

confidence: 99%

“…9,35,43 In response to this need, CTX administration safety standards since 2016 have included specific oral CTX standards as well as the addition of specific oral cancer agent issues such as the need to monitor adherence. 14,16,23,35,38,43…”

Section: /18mentioning

confidence: 99%

See 4 more Smart Citations

Patient Safety in the Administration of Antineoplastic Chemotherapy and of Immunotherapics for Oncological Treatment: Scoping Review

Oliveira

Santos

Bezerril

et al. 2019

Texto contexto - enferm.

View full text Add to dashboard Cite

Objective: to identify and synthesize the scientific evidence on cancer patient safety in the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Method: a scoping review, according to the Joanna Briggs Institute and to the recommendations of the PRISMA-ScR international guide. The research was conducted in five electronic databases, the Cochrane Library and eight catalogs of theses and dissertations. The inclusion criteria were the following: studies related to patient safety in the administration of antineoplastic and immunotherapeutic chemotherapy by nurses in places where cancer care occurs, published entirely in Portuguese, Spanish and/or English, with no time limit. The extracted data were analyzed and synthesized in narrative form. Results: a total of 14,444 records were retrieved and 47 studies were kept for review. Most publications (44.7%) had a qualitative approach, while 40.4% were quantitative and 14.9%, mixed. When summarizing the findings, the following themes emerged: Safety standards in parenteral administration of antineoplastic chemotherapy; Good practices for patient safety using oral antineoplastic therapy; Administration and safe handling of immunotherapies; Prevention and management of errors related to the administration of antineoplastic and immunotherapeutic chemotherapeutic agents. Conclusion: patients safety with cancer in the administration of antineoplastic therapy occurs when there is implementation of evidence-based protocols, continuing education of nurses and implementation of safety standards and processes, as a strategy to prevent errors in drug administration.

show abstract

Section: /18mentioning

confidence: 99%

Section: Good Practices For Patient Safety Using Oral Antineoplastic mentioning

confidence: 99%

Section: Good Practices For Patient Safety Using Oral Antineoplastic mentioning

confidence: 99%

Section: /18mentioning

confidence: 99%

Section: /18mentioning

confidence: 99%

See 3 more Smart Citations

Patient Safety in the Administration of Antineoplastic Chemotherapy and of Immunotherapics for Oncological Treatment: Scoping Review

Oliveira

Santos

Bezerril

et al. 2019

Texto contexto - enferm.

View full text Add to dashboard Cite

show abstract

Strategies to Improve Compliance with Clinical Nursing Documentation Guidelines in the Acute Hospital Setting: A Systematic Review and Analysis

Bunting¹,

Klerk²

2022

SAGE Open Nursing

View full text Add to dashboard Cite

Introduction This systematic review attempts to answer the following question – which strategies to improve clinical nursing documentation have been most effective in the acute hospital setting? Methods A keyword search for relevant studies was conducted in CINAHL and Medline in May 2019 and October 2020. Studies were appraised using the Joanna Briggs Institute (JBI) critical appraisal for quasi-experimental studies. The studies were graded for level of evidence according to GRADE principles. The data collected in each study were added to a Summary of Data (SOD) spreadsheet. Pre intervention and a post intervention percentage compliance scores were calculated for each study where possible i.e. (mean score/possible total score) × (100/1). A percentage change in compliance for each study was calculated by subtracting the pre intervention score from the post intervention score. The change in compliance score and the post intervention compliance score were both added to the SOD and used as a basis for comparison between the studies. Each study was analyzed thematically in terms of the intervention strategies used. Compliance rates and the interventions used were compared to determine if any strategies were effective in achieving a meaningful improvement in compliance. Results Seventy six full text articles were reviewed for this systematic review. Fifty seven of the studies were before and after studies and 66 were conducted in western countries. Publishing dates for the studies ranged from 1991 to 2020. Eleven studies included documentation audits with personal feedback as one of the strategies used to improve nursing documentation. Ten of these studies achieved a post intervention compliance rate ≥ 70%. Conclusion Notwithstanding the limitations of this study, it may be that documentation audit with personal feedback, when combined with other context specific strategies, is a reliable method for gaining meaningful improvements in clinical nursing documentation. The level of evidence is very low and further research is required.

show abstract

Nursing Application of Oral Chemotherapy Safety Standards:An Informal Survey

LeFebvre

Felice

2016

CJON

View full text Add to dashboard Cite

As the use of oral chemotherapy continues to rise, new approaches are needed to ensure patient safety. To help address this issue, the American Society of Clinical Oncology/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards were expanded in 2013 to include additional measures addressing oral anticancer drugs (OACs). Because minimal data assessing the application of these standards exist, ONS conducted an independent survey of oncology nurses to evaluate the application of these standards in practice as they relate to several areas of OAC use: assessment, consent, patient education, drug verification, and monitoring. The data revealed that, although the standards are followed in many settings, a large number of settings do not have processes in place to support safety standards and ensure patient safety when administering OACs. Information gained in this informal survey can be used to guide additional research and educational initiatives.

show abstract

Improving Documentation of Oral Chemotherapy at a Community Cancer Center

Abstract: We are hopeful that this improvement project will enhance patient safety by improving communication within the health care team regarding the details of the chemotherapy care plan.

Cited by 7 publications

References 3 publications

Patient Safety in the Administration of Antineoplastic Chemotherapy and of Immunotherapics for Oncological Treatment: Scoping Review

Patient Safety in the Administration of Antineoplastic Chemotherapy and of Immunotherapics for Oncological Treatment: Scoping Review

Strategies to Improve Compliance with Clinical Nursing Documentation Guidelines in the Acute Hospital Setting: A Systematic Review and Analysis

Nursing Application of Oral Chemotherapy Safety Standards:An Informal Survey

Contact Info

Product

Resources

About